Xeris Pharmaceuticals Inc (XERS NASDAQ) stock market data APIs
$6.5333
0.04(0.6%)
as of May 8, 2026
Try our APIs with
free plan!
Xeris Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Prev. Close
6.5333
Open
6.5733
High
6.5877
Low
6.3176
52 wk Range
4.3-10.08
Market Cap
1 127 M
P/E Ratio
93.2857
Shares Outstanding
173 M
Revenue
315 M
EPS
0.01
Beta
0.923
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Xeris Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Xeris Pharmaceuticals Inc data using free add-ons & libraries
Get Xeris Pharmaceuticals Inc Fundamental Data
Xeris Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 315 M
- EBITDA: 48 072 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Xeris Pharmaceuticals Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: 0.0135
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Xeris Pharmaceuticals Inc News
New
Xeris Biopharma Q1 Earnings Call Highlights
Xeris Biopharma logo Key Points Interested in Xeris Biopharma Holdings, Inc.? Here are five stocks we like better. Xeris Biopharma posted strong Q1 2026 results, with total revenue up 38% year over ...
Xeris Biopharma Holdings, Inc. Q4 2025 Earnings Call Summary
Xeris Biopharma Holdings, Inc. Q4 2025 Earnings Call Summary - Moby 2025 Performance and Strategic Execution Achieved a defining milestone of financial self-sustainability, effectively removing the ...
Xeris rises on 2026 revenue guidance, Q4 top-line beat
[Fourth Quarter Q4 Profits Stock Trading Chart 3D Background] * Xeris Biopharma (XERS [https://seekingalpha.com/symbol/XERS]) is up ~4% in Monday trading after posting 2026 revenue guidance above t...
Xeris Biopharma (XERS) Q4 2025 Earnings Transcript
Image source: The Motley Fool. DATE Monday, Mar. 2, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — John Shannon Chief Financial Officer — Steven Pieper Need a quote from a M...
Get Xeris Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
